|Mr. Kevin T. Conroy||Chairman, Pres & CEO||1.82M||845.39k||1966|
|Mr. Jeffrey T. Elliott CFA||Chief Financial Officer||701.77k||N/A||1978|
|Ms. Ana Hooker||Sr. VP of Operations||627.49k||N/A||1966|
|Mr. D. Scott Coward||Chief Admin. Officer, Sr. VP, Gen. Counsel & Sec.||741.87k||6.6M||1965|
|Mr. Jake Orville||Sr. VP of Pipeline||769.63k||N/A||1974|
|Mr. G. Bradley Cole||Gen. Mang. of Precision Oncology||1.23M||N/A||1956|
|Mr. Gary Frings||Chief Information Officer||N/A||N/A||N/A|
|Dr. Scott C. Johnson Ph.D.||Chief Science Officer and Sr. VP of R&D||N/A||N/A||N/A|
|Ms. Megan Jones||Associate Mang. of Investor Relations||N/A||N/A||N/A|
|Mr. Tim Caprez||Chief Compliance Counsel & VP||N/A||N/A||N/A|
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; and Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer. The company's pipeline products focuses on the research and development of enhancing Cologuard's performance characteristics, and blood or other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; Biocartis N.V.; and Hologic, Inc. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.
Exact Sciences Corporation’s ISS Governance QualityScore as of October 6, 2020 is 7. The pillar scores are Audit: 2; Board: 7; Shareholder Rights: 8; Compensation: 5.